(Total Views: 482)
Posted On: 02/01/2022 1:50:21 PM
Post# of 155808
Agree merge seems less likely than a partnership but I’m drawing parallels with smaller companies. GILD originally wanted to merge with IMMU.
Maybe I’m a little far off and buyout would be higher on the drawing board than merge but I just think a buyout is not happening.
Maybe someone can debunk what I’m saying or add to why a merge would make more sense than just a partnership. I just found it odd GILD was looking to merge originally with IMMU before a buyout.
Maybe I’m a little far off and buyout would be higher on the drawing board than merge but I just think a buyout is not happening.
Maybe someone can debunk what I’m saying or add to why a merge would make more sense than just a partnership. I just found it odd GILD was looking to merge originally with IMMU before a buyout.


Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com